BHF three-lens brief
Evidence-based stock research on BHF. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · RSI at 26 — technically oversold.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 26 — technically oversold.
- Underperforming SPY by 23.1pp over 30 days.
- P/E of 4.1 — trading at a value multiple.
- Analyst mean target $65.00 — 28% above current (6 analysts).
BHF closed at $50.84 (-0.61%) as of 2026-09-11. Market cap: $2.92B. P/E (trailing) 4.1. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 4.1 — trading at a value multiple.; analyst mean target $65.00 — 28% above current (6 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; rSI at 26 — technically oversold.. Last quarter: Revenue $2.10B, net income $956.00M, free cash flow $19.88B.
Why three lenses on BHF, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BHFacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BHF" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BHF brief"></iframe>